GILEAD SCIENCES INC → GALAPAGOS NV GLPGF

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

4 13D/G filings on this issuer

3 other filings besides this one

Filer Track Record

6 filings by this filer

5 other filings in the data moat

Short Interest · settle 2026-03-31

DTC 999.99

169,485 shares short · +153.3% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers

2 holders · $22.51M

Greenlight CapitalPoint72 Asset Mgmt

Other 13D/G Filings on GALAPAGOS NV

Filed	Form	Filer	Stake	Shares
2025-05-19	SCHEDULE	EcoR1 Capital, LLC	11.84%	7,803,202	view →
2025-01-10	SCHEDULE	GILEAD SCIENCES, INC.	29.90%	20,981,010	view →
2024-10-08	SC	EcoR1 Capital, LLC	—	—	view →

Other Filings by GILEAD SCIENCES INC

Filed	Form	Issuer	Stake	Shares
2025-02-20	SCHEDULE	Arcus Biosciences, Inc. RCUS	35.00%	39,691,649	view →
2025-01-10	SCHEDULE	GALAPAGOS NV GLPGF	29.90%	20,981,010	view →
2024-06-20	SC	ASSEMBLY BIOSCIENCES, INC. ASMB	—	—	view →
2023-07-06	SC	Arcus Biosciences, Inc. RCUS	—	—	view →
2021-02-02	SC	Arcus Biosciences, Inc. RCUS	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. $1,500/mo. Pilots welcome.

Request a pilot →